Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite...
Main Authors: | Udo Bonnet, Michael Specka, Michael Soyka, Thomas Alberti, Stefan Bender, Torsten Grigoleit, Leopold Hermle, Jörg Hilger, Thomas Hillemacher, Thomas Kuhlmann, Jens Kuhn, Christian Luckhaus, Christel Lüdecke, Jens Reimer, Udo Schneider, Welf Schroeder, Markus Stuppe, Gerhard A. Wiesbeck, Norbert Wodarz, Heath McAnally, Norbert Scherbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2020.592199/full |
Similar Items
-
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
by: Heath McAnally, et al.
Published: (2020-07-01) -
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
by: Benedikt Bernd Claus, et al.
Published: (2020-12-01) -
Gabapentinoids: condemned without sufficient evidence?
by: Udo Bonnet, et al.
Published: (2023-05-01) -
Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates
by: Udo Bonnet, et al.
Published: (2022-11-01) -
Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol
by: Heath McAnally
Published: (2017-11-01)